Monday, September 22, 2008

Ariad plans appeal of loss in Amgen case in D. Del.

The Boston Globe noted: Ariad Pharmaceuticals Inc. of Cambridge said Sept. 22 that it plans to pursue the "appropriate legal action" after a federal judge ruled against it in a patent dispute.

See also

More on Ariad/Lilly


Post a Comment

<< Home